InsidersTradesSigma
Follow the Diversicare Healthcare Services, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Diversicare Healthcare Services, Inc. has published 12 reports. The latest transaction was disclosed on 22 November 2021 (Disposition). Among the most active insiders: Osmium Partners, LLC. The full history is accessible without an account.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
11 ops.
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 November 2021
Declarations12 total
50,995 shares@ US$10.1050.0% of flowCommon StockSEC:0001209191-21-066011:0
42,792 shares@ US$10.1050.0% of flowCommon StockSEC:0001209191-21-066013:0
35,295 shares@ US$10.1050.0% of flowCommon StockSEC:0001209191-21-066012:0
8,048 shares@ US$10.1050.0% of flowCommon StockSEC:0001209191-21-066006:0
8,048 shares@ US$10.1050.0% of flowCommon StockSEC:0001209191-21-066007:0
52,831 shares@ US$10.1050.0% of flowCommon StockSEC:0001209191-21-066010:0
24,757 shares@ US$10.1050.0% of flowCommon StockSEC:0001209191-21-066009:0
13,219 shares@ US$10.1050.0% of flowCommon StockSEC:0001209191-21-066008:0
55,000 shares0Common StockSEC:0001209191-21-066014:0
35,954 shares@ US$9.69835.7% of flowCommon StockSEC:0001209191-21-055176:0
40,000 shares@ US$9.75340.2% of flowCommon StockSEC:0001209191-21-054474:0
23,950 shares@ US$9.743824.1% of flowCommon StockSEC:0001209191-21-053912:0
12 of 12 declarations
关于 Diversicare Healthcare Services, Inc.
Diversicare Healthcare Services, Inc.（股票代码：DVCR）是一家总部位于美国的急性后期护理运营商，在美国纳斯达克上市。该公司专注于专业护理中心，辅以康复服务、辅助医疗服务，并在某些地点提供辅助生活服务。其业务模式以住院后需要长期康复和支持的患者和居民为中心，这使得该公司对报销趋势和医疗政策变化高度敏感。（[sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000016/dvcr-20201231.htm?utm_source=openai)) Diversicare 于 1994 年在特拉华州注册成立，并通过在美国多个州的区域设施网络建立了其业务版图。SEC 文件显示，其历史业务主要分布在东南部、中西部和西南部，公司总部位于田纳西州布伦特伍德。这种区域集中使公司能够利用本地需求池，特别是在人口老龄化和急性后期护理需求支持长期利用的市场中。（[sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000016/dvcr-20201231.htm?utm_source=openai)) 运营方面，Diversicare 的核心业务线包括专业护理床位、物理/职业/言语治疗服务、呼吸服务、营养支持和其他专业辅助护理。从行业角度来看，该公司定位为急性后期护理提供商，而非广泛的急性护理医院连锁。其竞争优势通常体现在护理整合、对医学复杂患者的临床专业知识以及设施层面与社区需求的接近性。（[sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000016/dvcr-20201231.htm?utm_source=openai)) 竞争格局激烈且受到严格监管。专业护理提供商在联邦和州监督下运营，盈利能力在很大程度上取决于支付方组合，特别是医疗保险和医疗补助报销经济学。SEC 风险披露强调了报销率面临的压力、对高急性患者数量的敞口以及合规成本。对于投资者而言，这意味着该业务可以受益于稳定的本地需求，但其结构上仍然对利润率敏感。（[sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000016/dvcr-20201231.htm?utm_source=openai)) 最近一个值得注意的发展是 2021 年宣布的合并协议，这突显了外部对该特许经营权的战略兴趣，尽管最终结果和当前结构应与最新的 SEC 文件进行核对。对于投资者和市场参与者而言，DVCR 应被视为纳斯达克上市的美国小型医疗服务公司，其业绩受入住率、报销、劳动力成本和监管执行驱动，而非产品创新或全国规模。（[sec.gov](https://www.sec.gov/Archives/edgar/data/919956/000091995621000067/areannouncementofmergeragr.htm?utm_source=openai))
